0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oligosaccharide for Infant Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Published Date: 2026-06-15
|
Report Code: QYRE-Auto-30G14530
Home | Market Reports
Global Oligosaccharide for Infant Formula Market Research Report 2023
BUY CHAPTERS

Oligosaccharide for Infant Formula- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Code: QYRE-Auto-30G14530
Report
2026-06-15
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oligosaccharide for Infant Formula- Market

The global market for Oligosaccharide for Infant Formula was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Oligosaccharide for Infant Formula cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Oligosaccharides for infant formula refer to a group of carbohydrates that are added to infant formula to mimic the naturally occurring oligosaccharides found in human breast milk. Oligosaccharides are composed of a small number of sugar molecules linked together, typically ranging from two to ten sugar units.
Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby"s gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow"s milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.
The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby"s gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.
Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby"s immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.
It"s important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.
Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby"s gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow"s milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.
The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby"s gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.
Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby"s immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.
It"s important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.
This report provides a comprehensive view of the global market for Oligosaccharide for Infant Formula, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Oligosaccharide for Infant Formula market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Oligosaccharide for Infant Formula.
Market Segmentation

Scope of Oligosaccharide for Infant Formula- Market Report

Report Metric Details
Report Name Oligosaccharide for Infant Formula- Market
Segment by Type
  • Fructooligosaccharide
  • Galactooligosaccharides
  • Human Milk Oligosaccharides
Segment by Application
  • Standard
  • Follow on
  • Toddler
  • Specialty
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company FrieslandCampina, Meiji, Yakult, Baolingbao, Beneo-Orafti, Bailong, Ingredion, Sensus, QHT, Nikon Shikuhin KaKo, Nissin-sugar, Cosucra
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
  • Chapter 2: Provides a detailed analysis of the Oligosaccharide for Infant Formula manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
  • Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Presents Oligosaccharide for Infant Formula sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
  • Chapter 6: Presents Oligosaccharide for Infant Formula sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
  • Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
  • Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Oligosaccharide for Infant Formula- Market report?

Ans: The main players in the Oligosaccharide for Infant Formula- Market are FrieslandCampina, Meiji, Yakult, Baolingbao, Beneo-Orafti, Bailong, Ingredion, Sensus, QHT, Nikon Shikuhin KaKo, Nissin-sugar, Cosucra

What are the Application segmentation covered in the Oligosaccharide for Infant Formula- Market report?

Ans: The Applications covered in the Oligosaccharide for Infant Formula- Market report are Standard, Follow on, Toddler, Specialty

What are the Type segmentation covered in the Oligosaccharide for Infant Formula- Market report?

Ans: The Types covered in the Oligosaccharide for Infant Formula- Market report are Fructooligosaccharide, Galactooligosaccharides, Human Milk Oligosaccharides

1 Market Overview
1.1 Oligosaccharide for Infant Formula Product Introduction
1.2 Global Oligosaccharide for Infant Formula Market Size Forecast
1.2.1 Global Oligosaccharide for Infant Formula Sales Value (2021–2032)
1.2.2 Global Oligosaccharide for Infant Formula Sales Volume (2021–2032)
1.2.3 Global Oligosaccharide for Infant Formula Sales Price (2021–2032)
1.3 Oligosaccharide for Infant Formula Market Trends & Drivers
1.3.1 Oligosaccharide for Infant Formula Industry Trends
1.3.2 Oligosaccharide for Infant Formula Market Drivers & Opportunities
1.3.3 Oligosaccharide for Infant Formula Market Challenges
1.3.4 Oligosaccharide for Infant Formula Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oligosaccharide for Infant Formula Players Revenue Ranking (2025)
2.2 Global Oligosaccharide for Infant Formula Revenue by Company (2021–2026)
2.3 Global Oligosaccharide for Infant Formula Sales Volume Ranking of Players (2025)
2.4 Global Oligosaccharide for Infant Formula Sales Volume by Company (2021–2026)
2.5 Global Oligosaccharide for Infant Formula Average Price by Company (2021–2026)
2.6 Key Manufacturers Oligosaccharide for Infant Formula Manufacturing Base and Headquarters
2.7 Key Manufacturers Oligosaccharide for Infant Formula Product Offerings
2.8 Key Manufacturers Start of Mass Production of Oligosaccharide for Infant Formula
2.9 Oligosaccharide for Infant Formula Market Competitive Analysis
2.9.1 Oligosaccharide for Infant Formula Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Oligosaccharide for Infant Formula Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oligosaccharide for Infant Formula revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Oligosaccharide for Infant Formula Market Classification
3.1 Introduction by Type
3.1.1 Fructooligosaccharide
3.1.2 Galactooligosaccharides
3.1.3 Human Milk Oligosaccharides
3.1.4 Global Oligosaccharide for Infant Formula Sales Value by Type
3.1.4.1 Global Oligosaccharide for Infant Formula Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Oligosaccharide for Infant Formula Sales Value, by Type (2021–2032)
3.1.4.3 Global Oligosaccharide for Infant Formula Sales Value, by Type (%), 2021–2032
3.1.5 Global Oligosaccharide for Infant Formula Sales Volume by Type
3.1.5.1 Global Oligosaccharide for Infant Formula Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Oligosaccharide for Infant Formula Sales Volume, by Type (2021–2032)
3.1.5.3 Global Oligosaccharide for Infant Formula Sales Volume, by Type (%), 2021–2032
3.1.6 Global Oligosaccharide for Infant Formula Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Standard
4.1.2 Follow on
4.1.3 Toddler
4.1.4 Specialty
4.2 Global Oligosaccharide for Infant Formula Sales Value by Application
4.2.1 Global Oligosaccharide for Infant Formula Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Oligosaccharide for Infant Formula Sales Value, by Application (2021–2032)
4.2.3 Global Oligosaccharide for Infant Formula Sales Value, by Application (%), 2021–2032
4.3 Global Oligosaccharide for Infant Formula Sales Volume by Application
4.3.1 Global Oligosaccharide for Infant Formula Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Oligosaccharide for Infant Formula Sales Volume, by Application (2021–2032)
4.3.3 Global Oligosaccharide for Infant Formula Sales Volume, by Application (%), 2021–2032
4.4 Global Oligosaccharide for Infant Formula Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Oligosaccharide for Infant Formula Sales Value by Region
5.1.1 Global Oligosaccharide for Infant Formula Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Oligosaccharide for Infant Formula Sales Value by Region (2021–2026)
5.1.3 Global Oligosaccharide for Infant Formula Sales Value by Region (2027–2032)
5.1.4 Global Oligosaccharide for Infant Formula Sales Value by Region (%), 2021–2032
5.2 Global Oligosaccharide for Infant Formula Sales Volume by Region
5.2.1 Global Oligosaccharide for Infant Formula Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Oligosaccharide for Infant Formula Sales Volume by Region (2021–2026)
5.2.3 Global Oligosaccharide for Infant Formula Sales Volume by Region (2027–2032)
5.2.4 Global Oligosaccharide for Infant Formula Sales Volume by Region (%), 2021–2032
5.3 Global Oligosaccharide for Infant Formula Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Oligosaccharide for Infant Formula Sales Value, 2021–2032
5.4.2 North America Oligosaccharide for Infant Formula Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Oligosaccharide for Infant Formula Sales Value, 2021–2032
5.5.2 Europe Oligosaccharide for Infant Formula Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Oligosaccharide for Infant Formula Sales Value, 2021–2032
5.6.2 Asia Pacific Oligosaccharide for Infant Formula Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Oligosaccharide for Infant Formula Sales Value, 2021–2032
5.7.2 South America Oligosaccharide for Infant Formula Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oligosaccharide for Infant Formula Sales Value, 2021–2032
5.8.2 Middle East & Africa Oligosaccharide for Infant Formula Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oligosaccharide for Infant Formula Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Oligosaccharide for Infant Formula Sales Value and Sales Volume
6.2.1 Key Countries/Regions Oligosaccharide for Infant Formula Sales Value, 2021–2032
6.2.2 Key Countries/Regions Oligosaccharide for Infant Formula Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Oligosaccharide for Infant Formula Sales Value, 2021–2032
6.3.2 United States Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Oligosaccharide for Infant Formula Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Oligosaccharide for Infant Formula Sales Value, 2021–2032
6.4.2 Europe Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Oligosaccharide for Infant Formula Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Oligosaccharide for Infant Formula Sales Value, 2021–2032
6.5.2 China Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
6.5.3 China Oligosaccharide for Infant Formula Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Oligosaccharide for Infant Formula Sales Value, 2021–2032
6.6.2 Japan Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Oligosaccharide for Infant Formula Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Oligosaccharide for Infant Formula Sales Value, 2021–2032
6.7.2 South Korea Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Oligosaccharide for Infant Formula Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Oligosaccharide for Infant Formula Sales Value, 2021–2032
6.8.2 Southeast Asia Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Oligosaccharide for Infant Formula Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Oligosaccharide for Infant Formula Sales Value, 2021–2032
6.9.2 India Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
6.9.3 India Oligosaccharide for Infant Formula Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 FrieslandCampina
7.1.1 FrieslandCampina Company Information
7.1.2 FrieslandCampina Introduction and Business Overview
7.1.3 FrieslandCampina Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 FrieslandCampina Oligosaccharide for Infant Formula Product Offerings
7.1.5 FrieslandCampina Recent Developments
7.2 Meiji
7.2.1 Meiji Company Information
7.2.2 Meiji Introduction and Business Overview
7.2.3 Meiji Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Meiji Oligosaccharide for Infant Formula Product Offerings
7.2.5 Meiji Recent Developments
7.3 Yakult
7.3.1 Yakult Company Information
7.3.2 Yakult Introduction and Business Overview
7.3.3 Yakult Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Yakult Oligosaccharide for Infant Formula Product Offerings
7.3.5 Yakult Recent Developments
7.4 Baolingbao
7.4.1 Baolingbao Company Information
7.4.2 Baolingbao Introduction and Business Overview
7.4.3 Baolingbao Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Baolingbao Oligosaccharide for Infant Formula Product Offerings
7.4.5 Baolingbao Recent Developments
7.5 Beneo-Orafti
7.5.1 Beneo-Orafti Company Information
7.5.2 Beneo-Orafti Introduction and Business Overview
7.5.3 Beneo-Orafti Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Beneo-Orafti Oligosaccharide for Infant Formula Product Offerings
7.5.5 Beneo-Orafti Recent Developments
7.6 Bailong
7.6.1 Bailong Company Information
7.6.2 Bailong Introduction and Business Overview
7.6.3 Bailong Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Bailong Oligosaccharide for Infant Formula Product Offerings
7.6.5 Bailong Recent Developments
7.7 Ingredion
7.7.1 Ingredion Company Information
7.7.2 Ingredion Introduction and Business Overview
7.7.3 Ingredion Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Ingredion Oligosaccharide for Infant Formula Product Offerings
7.7.5 Ingredion Recent Developments
7.8 Sensus
7.8.1 Sensus Company Information
7.8.2 Sensus Introduction and Business Overview
7.8.3 Sensus Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Sensus Oligosaccharide for Infant Formula Product Offerings
7.8.5 Sensus Recent Developments
7.9 QHT
7.9.1 QHT Company Information
7.9.2 QHT Introduction and Business Overview
7.9.3 QHT Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 QHT Oligosaccharide for Infant Formula Product Offerings
7.9.5 QHT Recent Developments
7.10 Nikon Shikuhin KaKo
7.10.1 Nikon Shikuhin KaKo Company Information
7.10.2 Nikon Shikuhin KaKo Introduction and Business Overview
7.10.3 Nikon Shikuhin KaKo Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Nikon Shikuhin KaKo Oligosaccharide for Infant Formula Product Offerings
7.10.5 Nikon Shikuhin KaKo Recent Developments
7.11 Nissin-sugar
7.11.1 Nissin-sugar Company Information
7.11.2 Nissin-sugar Introduction and Business Overview
7.11.3 Nissin-sugar Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Nissin-sugar Oligosaccharide for Infant Formula Product Offerings
7.11.5 Nissin-sugar Recent Developments
7.12 Cosucra
7.12.1 Cosucra Company Information
7.12.2 Cosucra Introduction and Business Overview
7.12.3 Cosucra Oligosaccharide for Infant Formula Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Cosucra Oligosaccharide for Infant Formula Product Offerings
7.12.5 Cosucra Recent Developments
8 Industry Chain Analysis
8.1 Oligosaccharide for Infant Formula Industrial Chain
8.2 Oligosaccharide for Infant Formula Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Oligosaccharide for Infant Formula Sales Model
8.5.2 Sales Channels
8.5.3 Oligosaccharide for Infant Formula Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Oligosaccharide for Infant Formula Market Trends
 Table 2. Oligosaccharide for Infant Formula Market Drivers & Opportunities
 Table 3. Oligosaccharide for Infant Formula Market Challenges
 Table 4. Oligosaccharide for Infant Formula Market Restraints
 Table 5. Global Oligosaccharide for Infant Formula Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Oligosaccharide for Infant Formula Revenue Market Share by Company (2021–2026)
 Table 7. Global Oligosaccharide for Infant Formula Sales Volume by Company (Tons), 2021–2026
 Table 8. Global Oligosaccharide for Infant Formula Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Oligosaccharide for Infant Formula Price by Company (US$/Ton), 2021–2026
 Table 10. Key Manufacturers Oligosaccharide for Infant Formula Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Oligosaccharide for Infant Formula Product Type
 Table 12. Key Manufacturers Start of Mass Production of Oligosaccharide for Infant Formula
 Table 13. Global Oligosaccharide for Infant Formula Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Oligosaccharide for Infant Formula revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Oligosaccharide for Infant Formula Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Oligosaccharide for Infant Formula Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Oligosaccharide for Infant Formula Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Oligosaccharide for Infant Formula Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Oligosaccharide for Infant Formula Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Oligosaccharide for Infant Formula Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Oligosaccharide for Infant Formula Sales Volume by Type (Tons), 2021–2026
 Table 23. Global Oligosaccharide for Infant Formula Sales Volume by Type (Tons), 2027–2032
 Table 24. Global Oligosaccharide for Infant Formula Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Oligosaccharide for Infant Formula Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Oligosaccharide for Infant Formula Price by Type (US$/Ton), 2021–2026
 Table 27. Global Oligosaccharide for Infant Formula Price by Type (US$/Ton), 2027–2032
 Table 28. Global Oligosaccharide for Infant Formula Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Oligosaccharide for Infant Formula Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Oligosaccharide for Infant Formula Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Oligosaccharide for Infant Formula Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Oligosaccharide for Infant Formula Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Oligosaccharide for Infant Formula Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)
 Table 34. Global Oligosaccharide for Infant Formula Sales Volume by Application (Tons), 2021–2026
 Table 35. Global Oligosaccharide for Infant Formula Sales Volume by Application (Tons), 2027–2032
 Table 36. Global Oligosaccharide for Infant Formula Sales Market Share in Volume by Application (2021–2026)
 Table 37. Global Oligosaccharide for Infant Formula Sales Market Share in Volume by Application (2027–2032)
 Table 38. Global Oligosaccharide for Infant Formula Price by Application (US$/Ton), 2021–2026
 Table 39. Global Oligosaccharide for Infant Formula Price by Application (US$/Ton), 2027–2032
 Table 40. Global Oligosaccharide for Infant Formula Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Oligosaccharide for Infant Formula Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Oligosaccharide for Infant Formula Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Oligosaccharide for Infant Formula Sales Value by Region (%), 2021–2026
 Table 44. Global Oligosaccharide for Infant Formula Sales Value by Region (%), 2027–2032
 Table 45. Global Oligosaccharide for Infant Formula Sales Volume by Region (Tons): 2021 vs 2025 vs 2032
 Table 46. Global Oligosaccharide for Infant Formula Sales Volume by Region (Tons), 2021–2026
 Table 47. Global Oligosaccharide for Infant Formula Sales Volume by Region (Tons), 2027–2032
 Table 48. Global Oligosaccharide for Infant Formula Sales Volume by Region (%), 2021–2026
 Table 49. Global Oligosaccharide for Infant Formula Sales Volume by Region (%), 2027–2032
 Table 50. Global Oligosaccharide for Infant Formula Average Price by Region (US$/Ton), 2021–2026
 Table 51. Global Oligosaccharide for Infant Formula Average Price by Region (US$/Ton), 2027–2032
 Table 52. Key Countries/Regions Oligosaccharide for Infant Formula Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Oligosaccharide for Infant Formula Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Oligosaccharide for Infant Formula Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Oligosaccharide for Infant Formula Sales Volume, (Tons), 2021–2026
 Table 56. Key Countries/Regions Oligosaccharide for Infant Formula Sales Volume, (Tons), 2027–2032
 Table 57. FrieslandCampina Company Information
 Table 58. FrieslandCampina Introduction and Business Overview
 Table 59. FrieslandCampina Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 60. FrieslandCampina Oligosaccharide for Infant Formula Product Offerings
 Table 61. FrieslandCampina Recent Developments
 Table 62. Meiji Company Information
 Table 63. Meiji Introduction and Business Overview
 Table 64. Meiji Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 65. Meiji Oligosaccharide for Infant Formula Product Offerings
 Table 66. Meiji Recent Developments
 Table 67. Yakult Company Information
 Table 68. Yakult Introduction and Business Overview
 Table 69. Yakult Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 70. Yakult Oligosaccharide for Infant Formula Product Offerings
 Table 71. Yakult Recent Developments
 Table 72. Baolingbao Company Information
 Table 73. Baolingbao Introduction and Business Overview
 Table 74. Baolingbao Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 75. Baolingbao Oligosaccharide for Infant Formula Product Offerings
 Table 76. Baolingbao Recent Developments
 Table 77. Beneo-Orafti Company Information
 Table 78. Beneo-Orafti Introduction and Business Overview
 Table 79. Beneo-Orafti Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 80. Beneo-Orafti Oligosaccharide for Infant Formula Product Offerings
 Table 81. Beneo-Orafti Recent Developments
 Table 82. Bailong Company Information
 Table 83. Bailong Introduction and Business Overview
 Table 84. Bailong Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 85. Bailong Oligosaccharide for Infant Formula Product Offerings
 Table 86. Bailong Recent Developments
 Table 87. Ingredion Company Information
 Table 88. Ingredion Introduction and Business Overview
 Table 89. Ingredion Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 90. Ingredion Oligosaccharide for Infant Formula Product Offerings
 Table 91. Ingredion Recent Developments
 Table 92. Sensus Company Information
 Table 93. Sensus Introduction and Business Overview
 Table 94. Sensus Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 95. Sensus Oligosaccharide for Infant Formula Product Offerings
 Table 96. Sensus Recent Developments
 Table 97. QHT Company Information
 Table 98. QHT Introduction and Business Overview
 Table 99. QHT Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 100. QHT Oligosaccharide for Infant Formula Product Offerings
 Table 101. QHT Recent Developments
 Table 102. Nikon Shikuhin KaKo Company Information
 Table 103. Nikon Shikuhin KaKo Introduction and Business Overview
 Table 104. Nikon Shikuhin KaKo Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 105. Nikon Shikuhin KaKo Oligosaccharide for Infant Formula Product Offerings
 Table 106. Nikon Shikuhin KaKo Recent Developments
 Table 107. Nissin-sugar Company Information
 Table 108. Nissin-sugar Introduction and Business Overview
 Table 109. Nissin-sugar Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 110. Nissin-sugar Oligosaccharide for Infant Formula Product Offerings
 Table 111. Nissin-sugar Recent Developments
 Table 112. Cosucra Company Information
 Table 113. Cosucra Introduction and Business Overview
 Table 114. Cosucra Oligosaccharide for Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 115. Cosucra Oligosaccharide for Infant Formula Product Offerings
 Table 116. Cosucra Recent Developments
 Table 117. Key Raw Materials Lists
 Table 118. Key Suppliers of Raw Materials Lists
 Table 119. Oligosaccharide for Infant Formula Downstream Customers
 Table 120. Oligosaccharide for Infant Formula Distributors List
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources


List of Figures
 Figure 1. Oligosaccharide for Infant Formula Product Picture
 Figure 2. Global Oligosaccharide for Infant Formula Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 4. Global Oligosaccharide for Infant Formula Sales Volume (Tons), 2021–2032
 Figure 5. Global Oligosaccharide for Infant Formula Sales Price (US$/Ton), 2021–2032
 Figure 6. Oligosaccharide for Infant Formula Report Years Considered
 Figure 7. Global Oligosaccharide for Infant Formula Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Oligosaccharide for Infant Formula Sales Volume Ranking of Players (Tons), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oligosaccharide for Infant Formula Revenue in 2025
 Figure 10. Oligosaccharide for Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Fructooligosaccharide Picture
 Figure 12. Galactooligosaccharides Picture
 Figure 13. Human Milk Oligosaccharides Picture
 Figure 14. Global Oligosaccharide for Infant Formula Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Oligosaccharide for Infant Formula Sales Value Market Share by Type, 2025 & 2032
 Figure 16. Global Oligosaccharide for Infant Formula Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
 Figure 17. Global Oligosaccharide for Infant Formula Sales Volume Market Share by Type, 2025 & 2032
 Figure 18. Global Oligosaccharide for Infant Formula Price by Type (US$/Ton), 2021–2032
 Figure 19. Product Picture of Standard
 Figure 20. Product Picture of Follow on
 Figure 21. Product Picture of Toddler
 Figure 22. Product Picture of Specialty
 Figure 23. Global Oligosaccharide for Infant Formula Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 24. Global Oligosaccharide for Infant Formula Sales Value Market Share by Application, 2025 & 2032
 Figure 25. Global Oligosaccharide for Infant Formula Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
 Figure 26. Global Oligosaccharide for Infant Formula Sales Volume Market Share by Application, 2025 & 2032
 Figure 27. Global Oligosaccharide for Infant Formula Price by Application (US$/Ton), 2021–2032
 Figure 28. North America Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 29. North America Oligosaccharide for Infant Formula Sales Value by Country (%), 2025 vs 2032
 Figure 30. Europe Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 31. Europe Oligosaccharide for Infant Formula Sales Value by Country (%), 2025 vs 2032
 Figure 32. Asia Pacific Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 33. Asia Pacific Oligosaccharide for Infant Formula Sales Value by Region (%), 2025 vs 2032
 Figure 34. South America Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 35. South America Oligosaccharide for Infant Formula Sales Value by Country (%), 2025 vs 2032
 Figure 36. Middle East & Africa Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 37. Middle East & Africa Oligosaccharide for Infant Formula Sales Value by Country (%), 2025 vs 2032
 Figure 38. Key Countries/Regions Oligosaccharide for Infant Formula Sales Value (%), 2021–2032
 Figure 39. Key Countries/Regions Oligosaccharide for Infant Formula Sales Volume (%), 2021–2032
 Figure 40. United States Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 41. United States Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
 Figure 42. United States Oligosaccharide for Infant Formula Sales Value by Application (%), 2025 vs 2032
 Figure 43. Europe Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 44. Europe Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
 Figure 45. Europe Oligosaccharide for Infant Formula Sales Value by Application (%), 2025 vs 2032
 Figure 46. China Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 47. China Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
 Figure 48. China Oligosaccharide for Infant Formula Sales Value by Application (%), 2025 vs 2032
 Figure 49. Japan Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 50. Japan Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
 Figure 51. Japan Oligosaccharide for Infant Formula Sales Value by Application (%), 2025 vs 2032
 Figure 52. South Korea Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 53. South Korea Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
 Figure 54. South Korea Oligosaccharide for Infant Formula Sales Value by Application (%), 2025 vs 2032
 Figure 55. Southeast Asia Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 56. Southeast Asia Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
 Figure 57. Southeast Asia Oligosaccharide for Infant Formula Sales Value by Application (%), 2025 vs 2032
 Figure 58. India Oligosaccharide for Infant Formula Sales Value (US$ Million), 2021–2032
 Figure 59. India Oligosaccharide for Infant Formula Sales Value by Type (%), 2025 vs 2032
 Figure 60. India Oligosaccharide for Infant Formula Sales Value by Application (%), 2025 vs 2032
 Figure 61. Oligosaccharide for Infant Formula Industrial Chain
 Figure 62. Oligosaccharide for Infant Formula Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$3950

Single User License
Electronic

$5925

Multi User License
Electronic

$7900

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners